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Abstract
Fluorescence spectra of anti-tumoral drug emodin loaded on nanostructured porous silicon have been recorded.
The use of colloidal nanoparticles allowed embedding of the drug without previous porous silicon functionalization
and leads to the observation of an enhancement of fluorescence of the drug. Mean pore size of porous silicon
matrices was 60 nm, while silver nanoparticles mean diameter was 50 nm. Atmospheric and vacuum conditions at
room temperature were used to infiltrate emodin-silver nanoparticles complexes into porous silicon matrices. The
drug was loaded after adsorption on metal surface, alone, and bound to bovine serum albumin. Methanol and
water were used as solvents. Spectra with 1 μm spatial resolution of cross-section of porous silicon layers were
recorded to observe the penetration of the drug. A maximum fluorescence enhancement factor of 24 was obtained
when protein was loaded bound to albumin, and atmospheric conditions of inclusion were used. A better
penetration was obtained using methanol as solvent when comparing with water. Complexes of emodin remain
loaded for 30 days after preparation without an apparent degradation of the drug, although a decrease in the
enhancement factor is observed. The study reported here constitutes the basis for designing a new drug delivery
system with future applications in medicine and pharmacy.
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Background
Porous silicon (PSi) is a mesoporous material which has
been proposed for an increased number of drug delivery
applications in the last few years [1,2]. PSi, as well as
mesoporous silica materials [3,4], shows biodegradability
and biocompatibility; both of them being fundamental
requirements for the development of controlled-release
drug delivery system. PSi materials are termed “top-
down” materials as opposed to the synthesized mesopor-
ous molecular sieves, which are so called “bottom-up”
silica materials that refer to the self-assembly of silicon
oxide by means of polymeric templates determining
the structure obtained. Besides, the efficient visible
photoluminescence of PSi, as first reported by Canham
[5] in 1990, can be used as a sensing signal of the carried
drug, once it has been duly immobilized onto the
PSi surface which sometimes requires its adequate
functionalization [6-8]. PSi can also incorporate metal
nanoparticles (NPs) which are furthermore useful as
nanocarriers and imaging agents [9,10]. In particular,
noble metal NPs, due to their localized surface plasmon
resonances (LSPRs), enhance both Raman (surface-
enhanced Raman scattering, SERS) and fluorescence
(surface-enhanced fluorescence, SEF) signals, being pos-
sible to use such spectroscopic techniques as high sensi-
tivity detection routes for molecular sensing of the
loaded drugs even after releasing from the PSi matrix.
SERS substrates based on silver/PSi [11,12] systems or
silver/Si nanowires [13] have been reported. Regarding
SEF using silver/Si nanostructures, to our knowledge,
only two papers report some results in solution: one for
praxeodimium ions (Pr3+) [14] and the other for
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lanthanide ions [15], after adding the Ag supported on
Si to the sample solutions. In both cases, the authors
reported larger fluorescence enhancement factors (EF)
in the range from 10 to 200 with such Ag/Si materials
than that caused by unsupported silver NPs.
Emodin is a natural anthraquinone dye with anti-
tumoral activity [16], as well as laxative, anti-
inflammatory, anti-aggregation, and anti-ulcer effects;
whose SERS and SEF characterizations in Ag colloid sus-
pensions, as well as its interaction with bovine serum al-
bumin (BSA) at different pHs values, have been
thoroughly carried out in our group [17-21]. With all
this previous knowledge and taking into account the
interest in using PSi as a drug carrier, emodin/AgNPs
(Em/Ag) and emodin-BSA/AgNPs (Em-BSA/Ag) com-
plexes were loaded in PSi matrices and used as a model
system for other drugs, followed by the detection of
emodin through the corresponding SEF spectra. In order
to optimize the experimental variables, PSi layers with
different pore sizes were tested in different impregnation
conditions and the drug penetration in the PSi channels
was detected. In all cases, the spatial resolution was 1
μm. Besides, the variation of the emodin SEF signal with
time was monitored, from a freshly prepared sample
until 30 days, in order to evaluate the possible temporal
degradation. After verifying that the drug molecules did
not remain included into PSi channels, the use of AgNPs
allowed loading the drug without any functionalization.
The SEF measurements used in this work can discrimin-
ate between emodin monomer and their aggregates.
Only the monomer form of emodin was detected, thus,
avoiding possible adverse effects due to the presence of
drug agglomerates. Enhancement factor obtained for the
fluorescence signal of emodin in the samples studied by
SEF is in the range from 10 to 24.
Methods
Emodin, BSA, and hydroxylamine hydrochloride were
purchased from Sigma (Sigma-Aldrich Corporation, St.
Louis, MO, USA). Pure water was obtained from a Mili-
Q Integral A10 system from Millipore (Billerica, MA,
USA) and methanol (MeOH) was purchased from Pan-
reac (Barcelona, Spain).
Silver colloids were prepared using Leopold and Lendl
method [22]. Briefly, it consists of reducing an aqueous
solution of AgNO3 (10
−2 M) with hydroxylamine hydro-
chloride in basic medium. The mean diameter of silver
NPs obtained and evaluated by scanning electron micro-
scope (SEM) (images not shown) was 50 nm.
Nanostructured PSi layers were formed by electro-
chemical etch of boron-doped (p-type) silicon wafers
(orientation, <100> and resistivity, 0.01–0.02Ωcm).
The low-resistivity ohmic contacts were formed by coat-
ing the backside of the Si wafers with Al and
subsequently annealing at 400°C for 5 min. The electro-
lyte consisted of 1:2 HF (48 wt.%):ethanol (98 wt.%) so-
lution. The wafers were galvanostatically etched under
illumination from a 100 W halogen lamp. The etching
current density was typically 80 mA/cm2 and the etching
time was 120 seconds, leading to the formation of 5 to
7 μm-thick PSi layers with an average pore size around
60 nm. In order to fabricate PSi matrices with smaller
pore size, HF concentration in the etching process was
increased, leading a solution 2:1 HF (48 wt.%):ethanol
(98 wt.%). Also, the applied current density was reduced
to 20 mA/cm2. The resulting PSi layers were loaded by
capillarity suction in two different conditions, i.e., in at-
mospheric conditions and in vacuum at room
temperature.
Aliquots of an initial 2-mM emodin solution in MeOH
were diluted to obtain different concentrations to load
in PSi layers and get several samples to analyze. The
sample I (Em/Ag/MeOH) contained the drug adsorbed
on AgNPs surface using MeOH as solvent. Silver colloid,
freshly prepared, was centrifuged and the NPs redis-
persed in MeOH; subsequently, aliquot of initial emodin
solution was added to get 0.2 mM final concentration.
Sample II (Em/Ag/H2O) carried the drug adsorbed on
silver NPs using water as solvent. The final drug concen-
tration was the same as in sample I (Em/Ag/MeOH).
Sample III (Em-BSA/Ag/H2O) included the drug bound
to protein albumin forming BSA-emodin complexes. A
solid BSA was solved on fresh silver colloid; afterwards,
aliquot of emodin initial solution was added. Final
protein and drug concentrations were 0 and 0.2 mM.
Lastly, sample IV (Em/MeOH) was obtained by loading
a 0.2 mM solution of emodin in MeOH in absence of
AgNPs. Reference samples, named sample-ref I (Ag/
MeOH), sample-ref II (Ag/H2O), and sample-ref III
(BSA/Ag/H2O), were prepared following the same pro-
cedure as samples I, II, and III without including emo-
din. Wafers were transversally cut in order to analyze
the corresponding cross-sections.
Raman and fluorescence spectra were recorded in a
Renishaw inVia Raman microscope (Renishaw Iberica
SAU, Barcelona, Spain), using a 100x magnification ob-
jective (spectral resolution 2 cm−1). The excitation line,
532 nm, was provided by Nd:YAG laser. The output
laser power was 100 mW. The acquisition time of each
spectrum was 7 min. The spatial resolution was 1 μm.
Raman and fluorescence measurements of one cross-
section were taken in one-micron steps along the PSi
layer, from crystalline Si to open air. All spectra were
normalized to the Raman signal of crystalline Si in the
corresponding wafer.
The field emission scanning electron microscopy
(FE-SEM) images were taken with Hitachi SU8000 (Hita-
chi High-Technologies Corporation, Tokyo, Japan); SEM
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images were obtained using a JEOL JEM2000Fx (JEOL
Ltd., Tokyo, Japan).
Results and discussion
PSi layers were characterized morphologically by SEM
and spectroscopically by fluorescence and Raman. The
use of the appropriate fabrication parameters resulted in
PSi layers with two different pore sizes of 60 and 30 nm
as shown in Figure 1. The thicknesses of the layers were
of a few microns as can be seen in Figure 2.
Figure 3 shows the spectra of the cross-section sam-
ples when irradiating with 532 nm laser line. They
present characteristic Raman bands for the PSi, which
are different from that of Si [5]. Thus, while crystalline
silicon (Figure 3d) shows a characteristic thin and
symmetric band at 520 cm−1 and a wide band at 976 cm
−1, Raman bands of PSi (Figure 3b) appear at 503 cm−1
and 931 cm−1 respectively, and changed noticeably the
profile. From the Raman spectra, and following the
503 cm−1 PSi band, the thickness of the Psi layers could
be evaluated, being always in agreement with the SEM
images.
Photoluminescence of PSi is observed as a band, cen-
tered at 756 nm, as it is shown in Figure 4. The maximum
of this band reaches one fourth of the 503 cm−1. The
Raman band of PSi (marked with asterisk in Figure 4).
Measurements recorded at different positions in the
cross-section showed similar spectral shape and intensity,
thus indicating uniformity in the composition of the layer.
After 30 days of exposition to atmospheric conditions,
Figure 1 FE-SEM images of the cross-section of two PSi layers with different pore sizes: (a) 60 nm, (b) 30 nm.
Figure 2 SEM images of the cross-section of three of the samples analyzed. (a) Sample I (Em/Ag/MeOH), (b) sample II (Em/Ag/H2O), and (c)
sample III (Em-BSA/Ag/H2O). In all cases pore size is 60 nm.
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Raman bands from PSi remain unchanged, as shown in
Figure 4, whereas photoluminescence intensity decreases
on a 37% and blue-shift to 747 nm, indicating an oxidation
of PSi layer due to its exposition to air [23].
Figure 5 shows spectra from PSi matrices cross-
section obtained at 3 μm from Si-PSi interface, after the
matrices with an average pore size of 60 nm were loaded
with emodin and with Em/Ag complexes. The matrices
were loaded in atmospheric conditions. As reported be-
fore [20], emodin and emodin-silver complexes show
fluorescence after excitation at 514 nm. The lumines-
cence bands of PSi and emodin overlap. The analysis of
the fluorescence band indicates that when Em/Ag or
Em-BSA/Ag complexes are loaded, the position of the
maximum changes with regard to PSi (Figure 6). It shifts
to 730 nm which is the position reported previously for
the drug [20]. The profile of the band indicates mainly
the presence of monomer and the absence of aggregates
for emodin loaded on the nanostructured PSi matrices.
When Em/Ag or Em-BSA/Ag complexes were included
in the PSi, the fluorescence emission became more in-
tense than Raman bands of PSi, and the maximum peak
height was five times the 503 cm−1 Raman band of PSi.
In order to confirm if the dissimilarities of the fluores-
cence emission between pristine (fresh) and loaded PSi
corresponded to emodin or any of the other species
present in the system, prepared reference samples as
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Figure 3 Raman spectra of the cross-section of a PSi layer at
different positions. (a) PSi-air interface, (b) PSi, 3 μm from Si-PSi
interface, (c) Si-PSi interface, and (d) Si. Pore size is 60 nm.
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Figure 4 Fluorescence spectra of the cross-section of a PSi
layer of sample II(Em/Ag/H2O). Espectra are recorded on a point
situated at 3 μm from Si-PSi interface. (a) After 30 days preparation,
and (b) freshly prepared. Pore size is 60 nm. The Raman band of PSi
at 503 cm−1 is marked with an asterisk.
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Figure 5 Fluorescence spectra of the cross-section of several
PSi layers. Espectra are recorded on a point situated at 3 μm from
Si-PSi interface. (a) Loaded with sample-ref II (Ag/H2O), (b)
unloaded × 5, (c) loaded with sample IV (Em/MeOH) × 10, and (d)
loaded with sample II (Em/Ag/H2O). Pore size is 60 nm.
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Figure 6 Fluorescence spectra of the cross-section of loaded
PSi layers. Espectra are recorded on a point situated at 3 μm from
Si-PSi interface. (a) Sample I (Em/Ag/MeOH), (b) sample II (Em/Ag/
H2O), and (c) sample III (Em-BSA/Ag/H2O). Pore size is 60 nm.
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described above were studied. As it is shown in Figure 5,
when emodin and AgNPs are not present together, the
spectra show no remarkable differences with respect to
the PSi ones. This indicates that only a few number of
emodin molecules remain embedded on the PSi without
functionalization, and fluorescence can be mainly attrib-
uted to the mesoporous material. Moreover, it is neces-
sary that both components, emodin and AgNPs, were
coincident to enhance the fluorescence signal. When PSi
matrices with smaller size pore (30 nm) were loaded
with Em/Ag complexes, there was no change in the
photoluminescence of PSi (data not shown) indicating
no penetration of the AgNPs, since their size is larger
than that of the pores.
Hence, AgNPs present two principal advantages:
firstly, they act as a "linker" between the PSi surface and
the drug; secondly, they produce an enhancement of the
fluorescence of the drug signal due to the localized
surface plasmon resonance (LSPR) (SEF effect)
which is clearly perceptible. This enhancement of the
fluorescence varies with the solvent used in the loaded
process and decreases in all cases after 30 days of
preparation.
The “apparent” EF corresponding to the maximum sig-
nal of the cross-section for every sample can be seen in
Table 1. This factor was calculated using sample IV
(Em/MeOH) as reference. Values of the EF for the
freshly prepared samples when loading at atmospheric
conditions vary from 10 to 24. A higher enhancement
was obtained by loading sample III (Em-BSA/H2O),
where protein is present. The EF decreases for the two
solvents, water or alcohol, after 30 days of preparation
(Table 1). The enhancement of the fluorescence when
the PSi matrices were loaded in vacuum conditions,
showed in Table 1, indicates that Em/Ag complexes
present higher enhancements when they are loaded in
vacuum than in atmospheric conditions from a MeOH
solution. However, they exhibit lower enhancements
when they are loaded in vacuum than in atmospheric
conditions from a H2O solution. This behavior is due to
the different viscosity of each dissolvent which favors
one or the other conditions. No enhancement is
observed for Em-BSA/Ag complexes when they were
loaded in vacuum conditions. This is a consequence of
the conditions used which could affect the structure of
the protein and thus, consequently, the binding of the
drug to the protein.
As concentration of emodin in sample III (Em-BSA/
Ag) was ten times lower than that of other samples, the
EF estimated must be considered as a low threshold.
Experiments recorded with higher concentrations were
Table 1 Fluorescence enhancement factor of samples
studied
EF
Air, fresh Air, 30 days Vacuum, fresh
Sample I (Em/Ag/MeOH) 10 7 20
Sample II (Em/Ag/H2O) 14 5 5
Sample III (Em-BSA/Ag/H2O) 24 5 1
EF, maximum enhancement factor, for the fluorescence signal of emodin
when is adsorbed on AgNPs and loaded on PSi layers. Reference used is
sample IV (Em/MeOH).
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Figure 7 Intensity of fluorescence emission at 745 nm. Intensity of fluorescence emission, at 745 nm, of the cross-section of the samples
analyzed at different distances to the crystalline Si-PSi interface. Pore size is 60 nm.
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not possible because of solubility problems. Two simul-
taneous phenomena were present in these systems that
are absent in sample I (Em/Ag/MeOH) or sample II
(Em/Ag/H2O) and make fluorescence emission intensity
not proportional to concentration. The first one is the
inner filter effect [24], which is minimized on the geom-
etry used here, and affects all the samples studied. The
second one is the resonance energy transfer between the
protein, BSA, acting as a donor, and the emodin, acting
as an acceptor [17]. This effect is present only in sample
III (Em-BSA/Ag/H2O) and is derived from the overlap
between the protein emission and emodin excitation
spectra. Quantification of independent contributions is
difficult and is not necessary for an estimation of the
global EF presented in Table 1.
No SERS was observed in any of the samples. This is a
consequence of two factors; the first one is the high in-
tensity of the fluorescence, and second one is the ab-
sence of aggregating agent in the preparation of the
silver colloid, thus allowing SEF but hindering SERS
[25]. Only isolated NPs with smaller size than that of PSi
channels are able to penetrate in the pores. On the con-
trary, AgNPs aggregates produced by emodin, which also
aggregates in these conditions [18] and is responsible for
the SERS effect, remain on the surface of the PSi layers,
and are subsequently eliminated after washing of the
preparation of the samples. This was confirmed as un-
washed samples showed SERS spectra on the PSi-air
interface.
Spectra of the cross-section of the loaded PSi layers mea-
sured with one micron spatial resolution allowed detecting
the penetration of the drug in the PSi pores. Figure 7 shows
peak height of the fluorescence emission at 745 nm for all
the samples loaded in atmospheric conditions. The penetra-
tion is not the same for all the complexes, indicating the
sample preparation has a notable influence in the availabil-
ity of the drug to the PSi pore. Thus, Em/Ag complexes
loaded from a MeOH solution showed a different behavior
when H2O is the solvent. From MeOH solutions Em/Ag
complexes go deep into the pores and the quantity of mole-
cules loaded remains constant as it is deduced from the
similar values obtained for fluorescence intensity. In the
case of H2O solutions, the infiltration of Em/Ag complexes
is not uniform, and at about 3 or 4 μm, the maximum in-
tensity is observed. In the presence of BSA, the same be-
havior is observed due to the loading from a H2O solution.
After 30 days preparation, changes in intensity are notice-
able. In all cases, areas that are closer to the PSi-air inter-
face undergo higher changes, possibly due to the
consequent oxidation process [23].
Conclusions
PSi layers were fabricated and loaded with emodin by ca-
pillarity suction in atmospheric conditions and in vacuum.
The emission fluorescence of emodin and PSi overlap, and
signals are almost identical with no possibility of discrim-
ination. This problem has been overcome using silver col-
loid as drug carrier. Emodin was adsorbed on AgNPs
using either MeOH or H2O as solvent. The drug has also
been loaded bound to BSA, forming the transporter com-
plex. The presence of the AgNPs has been responsible of
the observation of SEF effect due to the existence of LSPR.
The differences in fluorescence drug intensity allowed
monitoring of its location in the PSi layer at different dis-
tances of the air-PSi interface.
The presence of protein gives the highest enhancement
factor of the drug fluorescence signal. In all cases mole-
cules, which are loaded, go 5 to 6 μm inside the pores.
Fluorescence signal decreases noticeably after 30 days of
preparation. Inclusion in atmospheric conditions gives
better results than in vacuum ones. In all cases emodin is
detected as monomer and no aggregate is observed. The
system presented allows the detection of low concentra-
tions of drugs and could constitute the basis for new drug
delivery systems used in medicine and pharmacy.
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